JP2023518838A5 - - Google Patents
Info
- Publication number
- JP2023518838A5 JP2023518838A5 JP2022557683A JP2022557683A JP2023518838A5 JP 2023518838 A5 JP2023518838 A5 JP 2023518838A5 JP 2022557683 A JP2022557683 A JP 2022557683A JP 2022557683 A JP2022557683 A JP 2022557683A JP 2023518838 A5 JP2023518838 A5 JP 2023518838A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- group
- phenyl
- epilepsy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062993359P | 2020-03-23 | 2020-03-23 | |
| US62/993,359 | 2020-03-23 | ||
| PCT/US2021/023653 WO2021195066A2 (en) | 2020-03-23 | 2021-03-23 | Kcnt1 inhibitors and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023518838A JP2023518838A (ja) | 2023-05-08 |
| JP2023518838A5 true JP2023518838A5 (enExample) | 2024-04-03 |
| JP7838820B2 JP7838820B2 (ja) | 2026-04-01 |
Family
ID=77892612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557683A Active JP7838820B2 (ja) | 2020-03-23 | 2021-03-23 | Ｋｃｎｔ１阻害剤及び使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230285377A1 (enExample) |
| EP (1) | EP4125831A4 (enExample) |
| JP (1) | JP7838820B2 (enExample) |
| KR (1) | KR20230005168A (enExample) |
| CN (2) | CN115715189B (enExample) |
| AU (1) | AU2021241530A1 (enExample) |
| BR (1) | BR112022019041A2 (enExample) |
| CA (1) | CA3176609A1 (enExample) |
| IL (1) | IL296649A (enExample) |
| MX (2) | MX2022011813A (enExample) |
| WO (1) | WO2021195066A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3139063A1 (en) * | 2019-05-03 | 2020-11-12 | Praxis Precision Medicines, Inc. | Kcnt1 inhibitors and methods of use |
| WO2020227097A1 (en) * | 2019-05-03 | 2020-11-12 | Praxis Precision Medicines, Inc. | Kcnt1 inhibitors and methods of use |
| CA3169779A1 (en) | 2020-02-28 | 2021-09-02 | Andrew Mark Griffin | Kcnt1 inhibitors and methods of use |
| US11773088B2 (en) | 2020-11-02 | 2023-10-03 | Praxis Precision Medicines, Inc. | KCNT1 inhibitors and methods of use |
| WO2023211854A1 (en) * | 2022-04-25 | 2023-11-02 | Praxis Precision Medicines, Inc. | Kcnt1 inhibitors comprising a thiazole core and methods of use |
| KR20250016137A (ko) * | 2022-04-25 | 2025-02-03 | 프락시스 프리시젼 메디신즈, 인크. | 피라졸 코어를 포함하는 kcnt1 억제제 및 사용 방법 |
| WO2023211850A1 (en) * | 2022-04-25 | 2023-11-02 | Praxis Precision Medicines, Inc. | Kcnt1 inhibitors comprising an isoxazole or oxadiazole core and methods of use |
| EP4630399A1 (en) * | 2022-12-05 | 2025-10-15 | Praxis Precision Medicines, Inc. | Kcnt1 inhibitors comprising a phenyl, pyridine, or pyrimidine core and methods of use |
| AR132248A1 (es) * | 2023-03-29 | 2025-06-11 | Merck Sharp & Dohme Llc | Inhibidores de il4i1 y métodos para su uso |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4471262B2 (ja) * | 2002-03-07 | 2010-06-02 | 株式会社エス・ディー・エス バイオテック | 置換イソキサゾールアルキルアミン誘導体及び農園芸用殺菌剤 |
| KR101195801B1 (ko) * | 2004-06-18 | 2012-11-05 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Ｘａ 인자 억제제 |
| CA2663408C (en) * | 2006-09-15 | 2011-11-01 | Pfizer Inc. | Substituted pyridylmethyl bicyclocarboxyamide compounds |
| US9321727B2 (en) * | 2011-06-10 | 2016-04-26 | Hoffmann-La Roche Inc. | Pyridine derivatives as agonists of the CB2 receptor |
| TW201642855A (zh) * | 2015-03-10 | 2016-12-16 | 健臻公司 | 用於治療蛋白質病變之方法 |
| US10538516B2 (en) * | 2015-03-25 | 2020-01-21 | National Center For Geriatrics And Gerontology | Oxadiazole derivative and pharmaceutical containing same |
-
2021
- 2021-03-23 AU AU2021241530A patent/AU2021241530A1/en active Pending
- 2021-03-23 KR KR1020227036699A patent/KR20230005168A/ko active Pending
- 2021-03-23 IL IL296649A patent/IL296649A/en unknown
- 2021-03-23 EP EP21774687.4A patent/EP4125831A4/en active Pending
- 2021-03-23 JP JP2022557683A patent/JP7838820B2/ja active Active
- 2021-03-23 WO PCT/US2021/023653 patent/WO2021195066A2/en not_active Ceased
- 2021-03-23 BR BR112022019041A patent/BR112022019041A2/pt unknown
- 2021-03-23 US US17/906,893 patent/US20230285377A1/en active Pending
- 2021-03-23 MX MX2022011813A patent/MX2022011813A/es unknown
- 2021-03-23 CA CA3176609A patent/CA3176609A1/en active Pending
- 2021-03-23 CN CN202180035479.0A patent/CN115715189B/zh active Active
- 2021-03-23 CN CN202610125645.0A patent/CN121868303A/zh active Pending
-
2022
- 2022-09-22 MX MX2026000122A patent/MX2026000122A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518838A5 (enExample) | ||
| JP2022530989A5 (enExample) | ||
| AU2019283921B2 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| JP2023532985A5 (enExample) | ||
| JP2022531388A5 (enExample) | ||
| AU2017213628B2 (en) | Inhibitors of receptor-interacting protein kinase 1 | |
| JP5690823B2 (ja) | Ｊａｋ受容体およびタンパク質チロシンキナーゼ阻害薬としての複素環化合物 | |
| JP2023515576A5 (enExample) | ||
| JP2011529029A5 (enExample) | ||
| MX2014008143A (es) | Inhibidores de bromodominio. | |
| JP2014506599A5 (enExample) | ||
| CA2966423C (en) | Potent gamma-secretase modulators | |
| JP2009532452A5 (enExample) | ||
| JP2010513519A5 (enExample) | ||
| JP2015516429A5 (enExample) | ||
| CN101918079A (zh) | 蛋白激酶抑制剂及其用途 | |
| WO2013188381A1 (en) | Pyridinone and pyridazinone derivatives | |
| EA023824B1 (ru) | ПРОИЗВОДНЫЕ 3,4-ДИГИДРОПИРРОЛО[1,2-a]ПИРАЗИН-1-ИЛАМИНА, ПРИГОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ БЕТА-СЕКРЕТАЗЫ (BACE) | |
| JPWO2020017587A5 (enExample) | ||
| CA2611530A1 (en) | Tyrosine kinase inhibitors | |
| RU2017106489A (ru) | 6,7-дигидропиразоло[1,5-а]пиразин-4(5h)-оновые соединения и их применение в качестве отрицательных аллостерических модуляторов рецепторов mglur2 | |
| JP2017523202A5 (enExample) | ||
| JP2024518792A5 (enExample) | ||
| JP2013533868A (ja) | タンパク質チロシンキナーゼ阻害剤としての新規ホモピペラジン誘導体およびそれらの医薬使用 | |
| RU2017106100A (ru) | 6,7-ДИГИДРОПИРАЗОЛО[1,5-α]ПИРАЗИН-4(5Н)-ОНОВЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ОТРИЦАТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ MGLUR2 |